Insuran R: Russian manufacturer of short-acting insulin
Insuran R is one of the leading short-acting insulin preparations produced in Russia. It belongs to the pharmaceutical group of short-acting insulins and has a wide range of applications in the treatment of diabetes mellitus.
The country of origin of Insuran R is Russia. The drug is produced at the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (Russian Academy of Sciences), which is one of the leading research institutions in the field of chemistry and biochemistry.
Insuran R is a soluble insulin obtained using genetic engineering methods. Its international name is “Soluble insulin (human genetically engineered).” The drug has various synonyms, including Actrapid HM, Biosulin R, Gansulin R, Insulin Humulin R, and others.
Insuran R is available in the form of an injection solution with different concentrations: 40 IU/ml and 100 IU/ml. This allows you to select the optimal dosage for the patient depending on his needs.
The production of Insuran R is carried out at the Institute of Bioorganic Chemistry named after Academicians M.M. Shemyakin and Yu.A. Ovchinnikov RAS. This institute has extensive experience in the development and production of biologically active substances, including insulin.
Insuran R is an important medication for many patients with diabetes, especially those who require regular insulin to maintain normal blood glucose levels. It helps control sugar levels and prevent possible complications associated with diabetes.
In conclusion, Insuran R is a Russian short-acting insulin preparation developed and produced at the Institute of Bioorganic Chemistry of the Russian Academy of Sciences. It is an important tool in the treatment of diabetes mellitus and helps improve the quality of life of patients requiring insulin therapy.